Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

Trial Profile

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2009

At a glance

  • Drugs Gliclazide; Perindopril/indapamide
  • Indications Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms AdRem; ADVANCE
  • Most Recent Events

    • 01 Oct 2009 Status changed from not stated to completed based on publication of results in Diabetologia.
    • 01 Oct 2009 Results were published in Diabetologia.
    • 29 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top